ProCE Banner Series

Elevating the Role of Cardiologists in Diabetes Care: Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists

Join us for an interactive presentation where leading experts provide insight on strategies to reduce cardiovascular risk through the use of GLP-1 receptor agonists. 

Who Should Attend

This program is intended for cardiologists, primary care physicians, endocrinologists and other HCPs who manage patients with T2D with risk factors or established CV disease.

All Events

Elevating the Role of Cardiologists in Diabetes Care: Cardiovascular Risk Reduction Strategies with GLP-1 Receptor Agonists

Past Events




6:00 PM - 7:00 PM Central Time (CT)





7:00 PM - 8:00 PM Eastern Time (ET)





6:00 PM - 7:00 PM Mountain Time (MT)





6:00 PM - 7:00 PM Central Time (CT)





6:00 PM - 7:00 PM Eastern Time (ET)





6:30 PM - 7:30 PM Eastern Time (ET)



ProCE Banner Faculty
Payal Kohli, MD, FACC

Associate Adjunct Professor in Cardiology Division, Department of Medicine, Duke University
Associate Clinical Professor of Medicine, University of Colorado Anshutz
Founder and Medical Director, Cherry Creek Heart
On-Air Medical Expert, Tegna Broadcasting
Aurora, Colorado

ProCE Banner Faculty
Darren K. McGuire, MD, MHSc, FACC

Distinguished Teaching Professor of Medicine
Jere H. Mitchell, MD Distinguished Chair in Cardiovascular Science
Division of Cardiology, Department of Medicine
University of Texas Southwestern Medical Center
Dallas, Texas

ProCE Banner Faculty
Anne Peters, MD

USC Clinical Diabetes Programs
Professor of Clinical Medicine
Keck School of Medicine of USC
University of Southern California
Los Angeles, California

ProCE Banner Faculty
Richard E. Pratley, MD

Samuel E. Crockett Chair in Diabetes Research
Medical Director
AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine
Orlando, Florida


Prevalence and Burden of CVD in T2DM
Discussion of Current Barriers and the Role of Cardiology 
Overview of GLP-1 RA‒Based Therapies
Comparison of CV Risk Reduction Profiles for GLP-1 RA‒Based Therapies
Expert Discussion of Patient Cases on Incorporating GLP-1 RAs Into Cardiology Practice   
Closing Remarks
Question and Answer Session


Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with type 2 diabetes (T2D) at high risk of cardiovascular events.

Target Audience
This program is intended for cardiologists, primary care physicians, endocrinologists, and other HCPs who manage patients with T2D with risk factors or established CV disease.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate the latest CV outcomes data and guideline recommendations for GLP-1 RA therapies in the management of T2D 
  • Compare the clinical profiles of GLP-1 RA based therapies for the management of T2D
  • Incorporate GLP-1 RAs into the treatment of patients with T2D and CV risk based on dosing recommendations, the latest evidence, and patient needs


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC point, your information will be shared with the ABIM through CCO’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC point to appear on your ABIM records.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Provided by Clinical Care Options, LLC

This activity is supported by an educational grant from Novo Nordisk.